KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to New York

S6736 • 2025

Relates to requiring Medicaid to cover a wearable medical device to treat certain forms of cancer

Relates to requiring Medicaid to cover a wearable medical device to treat certain forms of cancer

Healthcare
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Patricia Fahy
Last action
2026-06-04
Official status
In Assembly Committee
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Relates to requiring Medicaid to cover a wearable medical device to treat certain forms of cancer

Relates to requiring Medicaid to cover a wearable medical device to treat certain forms of cancer Requires Medicaid to cover a wearable medical device that uses low-intensity, alternating electric fields delivered to the tumor site to treat glioblastoma and other cancers as recommended by medical and scientific evidence.

What This Bill Does

  • Relates to requiring Medicaid to cover a wearable medical device to treat certain forms of cancer Requires Medicaid to cover a wearable medical device that uses low-intensity, alternating electric fields delivered to the tumor site to treat glioblastoma and other cancers as recommended by medical and scientific evidence.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-06-04 Senate

    COMMITTEE DISCHARGED AND COMMITTED TO RULES

  2. 2026-06-04 Senate

    ORDERED TO THIRD READING CAL.1714

  3. 2026-06-04 Senate

    PASSED SENATE

  4. 2026-06-04 Senate

    DELIVERED TO ASSEMBLY

  5. 2026-06-04 Assembly

    REFERRED TO HEALTH

  6. 2026-01-07 Assembly

    DIED IN ASSEMBLY

  7. 2026-01-07 Assembly

    RETURNED TO SENATE

  8. 2026-01-07 Senate

    REFERRED TO HEALTH

  9. 2025-06-09 Senate

    COMMITTEE DISCHARGED AND COMMITTED TO RULES

  10. 2025-06-09 Senate

    ORDERED TO THIRD READING CAL.1699

  11. 2025-06-09 Senate

    PASSED SENATE

  12. 2025-06-09 Senate

    DELIVERED TO ASSEMBLY

  13. 2025-06-09 Assembly

    REFERRED TO HEALTH

  14. 2025-05-28 Senate

    REPORTED AND COMMITTED TO FINANCE

  15. 2025-05-19 Senate

    AMEND AND RECOMMIT TO HEALTH

  16. 2025-05-19 Senate

    PRINT NUMBER 6736A

  17. 2025-03-21 Senate

    REFERRED TO HEALTH

Official Summary Text

Relates to requiring Medicaid to cover a wearable medical device to treat certain forms of cancer
Requires Medicaid to cover a wearable medical device that uses low-intensity, alternating electric fields delivered to the tumor site to treat glioblastoma and other cancers as recommended by medical and scientific evidence.

Current Bill Text

Read the full stored bill text 
S T A T E   O F   N E W   Y O R K
        ________________________________________________________________________

                                          6736

                               2025-2026 Regular Sessions

                                    I N  S E N A T E

                                     March 21, 2025
                                       ___________

        Introduced  by  Sen.  FAHY  --  read twice and ordered printed, and when
          printed to be committed to the Committee on Health

        AN ACT to amend the social services law, in relation to requiring  Medi-
          caid  to  cover  a  wearable  medical device to treat certain forms of
          cancer

          THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
        BLY, DO ENACT AS FOLLOWS:

     1    Section  1.  Subdivision 2 of section 365-a of the social services law
     2  is amended by adding a new paragraph (nn) to read as follows:
     3    (NN) A WEARABLE MEDICAL DEVICE THAT  USES  LOW-INTENSITY,  ALTERNATING
     4  ELECTRIC  FIELDS DELIVERED DIRECTLY TO THE TUMOR SITE TO TREAT GLIOBLAS-
     5  TOMA  AND  OTHER  CANCERS  AS  RECOMMENDED  BY  MEDICAL  AND  SCIENTIFIC
     6  EVIDENCE, INCLUDING, BUT NOT LIMITED TO:
     7    (I)  LABELED  INDICATIONS  FOR A MEDICAL DEVICE APPROVED OR CLEARED BY
     8  THE FEDERAL FOOD AND DRUG ADMINISTRATION;
     9    (II) CENTERS FOR MEDICARE  AND  MEDICAID  SERVICES  NATIONAL  COVERAGE
    10  DETERMINATIONS  AND  MEDICARE  ADMINISTRATIVE  CONTRACTOR LOCAL COVERAGE
    11  DETERMINATIONS; AND
    12    (III) NATIONALLY RECOGNIZED CLINICAL PRACTICE GUIDELINES SUCH AS,  BUT
    13  NOT  LIMITED  TO,  THOSE OF THE NATIONAL COMPREHENSIVE CANCER NETWORK OR
    14  THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY.
    15    § 2. This act shall take effect April 1, 2025.




         EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10904-01-5